Iridian Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $64.9M | Buy |
|
|||||
|
2018
Q2 | $65.1M | Sell |
|
|||||
|
2018
Q1 | $46M | Sell |
|
|||||
|
2017
Q4 | $48.2M | Buy |
|
|||||
|
2017
Q3 | $48.6M | Buy |
|
|||||
|
2017
Q2 | $54.8M | Sell |
|
|||||
|
2017
Q1 | $62.6M | Buy |
|
|||||
|
2016
Q4 | $3.15M | Buy |
|
|||||
|
2016
Q3 | $1.9M | Buy |
|
|||||
|
2016
Q2 | $798K | Buy |
|